Healing the gut may be the key to improving long-term recovery in stroke patients, scientists at Texas A&M University have found.

A paper published this fall by researchers in the Department of Neuroscience and Experimental Therapeutics at the Texas A&M College of Medicine is the latest of multiple studies highlighting the potential of this novel avenue of treatment, which takes advantage of the link between the brain and digestive system to curb cognitive impairment and other lingering impacts of a stroke or brain trauma.

UCSF Benioff Children's Hospital Oakland is enrolling patients in an innovative clinical trial that seeks to cure sickle cell disease. The trial is the first in the U.S. to apply non-viral CRISPR-Cas9 gene-editing technology in humans to directly correct the genetic mutation that causes the disease. The trial is part of a UC research consortium led by UCSF with UCLA and UC Berkeley.